OClawVPS.com
Edit

MiLaboratories

https://milaboratories.com/
Last activity: 07.06.2025
Active
Categories: BuildingPlatformSoftware
MiLaboratories is a company that provides software solutions for analyzing genomic diversity of antibodies and T-cell receptors. Their flagship product, MiXCR, is one of the most popular solutions in academia and pharmaceutical companies. The company has experience in the field of adaptive immunity starting from 2009.
Mentions
7
Location: United States, California, Sunnyvale
Employees: 11-50
Total raised: $12.3M
Founded date: 2021

Investors 1

DateNameWebsite
07.06.2025TEN13ten13.vc

Funding Rounds 2

DateSeriesAmountInvestors
10.10.2024Series A$10M-
22.02.2022-$2.3M-

Mentions in press and media 7

DateTitleDescription
14.10.2024Last week recap: European tech companies raised over €956M, around 73% collected by 10 biggest dealsLast week, we tracked more than 70 tech funding deals worth over €956 million, and over 5 exits, M&A transactions, rumours, and related news stories across Europe. In Q3 2024, European tech companies raised €11 billion over 891 deals. C...
10.10.2024MiLaboratories Raises Series A; Total Funding to $10MMiLaboratories, a San Francisco, CA-based company which specializes in computational biology innovation, raised an undisclosed amount in Series A funding. The round, which brought the total amount to $10M, was led by Kfund with participatio...
09.06.2022Acrobator Ventures launches new €30 million fund that aims to go the distanceInitially targeting ​​€20 million, Amsterdam-based VC firm Acrobator seen an oversubscription rate that’s well on its way to hitting a self-imposed hard cap at €30 million to fund startups in the CEE, CIS, and Baltics regions that have alre...
22.02.2022Used in the discovery of COVID-19 vaccines, genomics data analyses SaaS MiLaboratories raises $2.3 millionMiLaboratories, makers of MiXCR, a software suite that analyses genomics data to build a complete picture of immune response at the DNA level, has raised $2.3 million in a seed funding round. The capital will be used to develop a next-gener...
-Used in the discovery of COVID-19 vaccines, genomics data analyses SaaS MiLaboratories raises $2.3 millionMiLaboratories, makers of MiXCR, a software suite that analyses genomics data to build a complete picture of immune response at the DNA level, has raised $2.3 million in a seed funding round. The capital will be used to develop a next-gener...
-Acrobator Ventures launches new €30 million fund that aims to go the distanceInitially targeting ​​€20 million, Amsterdam-based VC firm Acrobator seen an oversubscription rate that’s well on its way to hitting a self-imposed hard cap at €30 million to fund startups in the CEE, CIS, and Baltics regions that have alre...
-MiLaboratories“Top-notch solutions for adaptive immunity studies”

Reviews 0

Sign up to leave a review

Sign up Log In